A detailed history of Oliver Lagore Vanvalin Investment Group transactions in Johnson & Johnson stock. As of the latest transaction made, Oliver Lagore Vanvalin Investment Group holds 986 shares of JNJ stock, worth $152,869. This represents 0.04% of its overall portfolio holdings.

Number of Shares
986
Previous 1,076 8.36%
Holding current value
$152,869
Previous $157,000 1.27%
% of portfolio
0.04%
Previous 0.05%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$145.48 - $167.38 $13,093 - $15,064
-90 Reduced 8.36%
986 $159,000
Q2 2024

Aug 15, 2024

SELL
$144.38 - $157.78 $48,078 - $52,540
-333 Reduced 23.63%
1,076 $157,000
Q1 2024

May 15, 2024

SELL
$155.22 - $162.74 $703,301 - $737,374
-4,531 Reduced 76.28%
1,409 $222,000
Q4 2023

Jan 31, 2024

BUY
$145.6 - $158.88 $291 - $317
2 Added 0.03%
5,940 $931,000
Q3 2023

Nov 09, 2023

BUY
$155.75 - $174.48 $35,978 - $40,304
231 Added 4.05%
5,938 $924,000
Q2 2023

Aug 08, 2023

BUY
$154.35 - $166.11 $287,862 - $309,795
1,865 Added 48.54%
5,707 $944,000
Q1 2023

Jun 20, 2023

BUY
$151.05 - $180.26 $107,396 - $128,164
711 Added 22.71%
3,842 $595,000
Q4 2022

Mar 02, 2023

SELL
$160.2 - $179.79 $286,758 - $321,824
-1,790 Reduced 36.37%
3,131 $553,000
Q3 2022

Nov 15, 2022

BUY
$161.33 - $179.52 $150,520 - $167,492
933 Added 23.4%
4,921 $804,000
Q2 2022

Aug 16, 2022

BUY
$168.19 - $186.01 $59,034 - $65,289
351 Added 9.65%
3,988 $708,000
Q1 2022

Jun 17, 2022

SELL
$158.14 - $179.59 $4.54 Million - $5.16 Million
-28,723 Reduced 88.76%
3,637 $634,000
Q4 2021

Mar 23, 2022

BUY
$155.93 - $173.01 $5.05 Million - $5.6 Million
32,360 New
32,360 $5.54 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $405B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Oliver Lagore Vanvalin Investment Group Portfolio

Follow Oliver Lagore Vanvalin Investment Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oliver Lagore Vanvalin Investment Group, based on Form 13F filings with the SEC.

News

Stay updated on Oliver Lagore Vanvalin Investment Group with notifications on news.